4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-061253
Chief Business Officer sold 6,945 shares at $31.53 ($218,968)
- Chief Business Officer acquired 6,945 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…